Despite diagnostic uncertainty, IVIG therapy was continued based on clinical suspicion. Anti-acetylcholine receptor (AChR) and anti-muscle-specific kinase (anti-MuSK) antibodies returned negative, significantly reducing suspicion for NMJ disorders such as MG or LEMS. The gene discussed is MUSK; the disease is Lambert-Eaton myasthenic syndrome.